Virgin Islands Water and Power Authority; Retail Electric Jan 12

  • ID: 2038668
  • January 2012
  • Region: Virgin Islands
  • Standard & Poors
1 of 3

Standard & Poor's Ratings Services has assigned its 'BBB-' rating to Virgin Islands Water and Power Authority's (WAPA) electric system revenue bonds, series 2012A, 2012B, and 2012C. At the same time, Standard & Poor's affirmed its 'BBB-' rating on WAPA's debt outstanding. The outlook is stable. Net electric system revenues secure the bonds. The 'BBB-' rating reflects our assessment of the following factors, which we view as credit weaknesses: High dependence on a single fuel type (oil), which we believe results in volatile rates and vulnerability to price spikes; High leverage, due in part to a $40 million deficit financing linked to high oil prices the past three years that reduced debt service coverage (DSC) levels; A low cash position,...

Companies mentioned in this report are: Virgin Islands Wtr & Pwr Auth
Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown
2 of 3

Virgin Islands Wtr & Pwr Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.